Exercise Program in Women With Metabolic Syndrome
2 november 2017 uppdaterad av: Vera Novak, Beth Israel Deaconess Medical Center
The Effect of Mixed Aerobic and Strength Training Program on Physical Fitness and Cerebrovascular Function in Older Women With Metabolic Syndrome: A Pilot Study With Randomized Control Trial (RCT) Design
The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
Studieöversikt
Detaljerad beskrivning
Metabolic syndrome is a cluster of conditions and disorders that increase the risk for coronary artery disease (CAD) and strokes.
Sedentary lifestyle is one of the risk factors, which decrease overall physical fitness and together with aging may lead to decrease in physical functioning in everyday life as well as changes in blood flow in the brain and cognitive functions.
Regular physical activity is associated with a reduced risk of cardiovascular disease.
It may also improve blood flow velocity and cognitive functions.
Physical activity should be as effective as possible, but also as safe as possible.
Supervised mixed aerobic and strength training (MAST) program for 4 months enables to individualize the intensity of aerobic exercise based on measured maximal exercise capacity.
Throughout each training session heart rate will be monitored with a new real time wireless ECG system.
Studietyp
Interventionell
Inskrivning (Faktisk)
28
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02215
- Beth Israel Deaconess Medical Center, Harvard University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
50 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Kvinna
Beskrivning
Inclusion Criteria:
- Post-menopausal women
- Age 50 or over
- Diagnosed metabolic syndrome
Exclusion Criteria:
- Any unstable or acute medical condition that the study physician deem unsafe for participation
- Positive stress test for CAD or other ischemic conditions
- Myocardial infarction or major surgery within 6 months
- History of a clinically documented stroke
- Clinical dementia (by history) or inability to follow details of the protocol
- Carotid stenosis > 50% by medical history
- Insulin dependent diabetes mellitus (also type II, if using insulin) or history of severe hypoglycemic episodes within 6 months requiring hospitalization
- Liver or renal failure or transplant
- Severe blood pressure elevation (systolic BP > 180 and/or diastolic BP > 110 mm Hg)
- Anemia (Hb < 10)
- Seizure disorders
- Current recreational drug or alcohol abuse
- BMI > 45, but body weight under 280 lbs
- Inability to obtain permission for participation from the primary care physician
- Clinically significant and movement limiting hip, knee and/or back disorders or injury, and rheumatoid arthritis
- Transcranial Doppler (TCD) exclusion criteria - poor insonation window and TCD signal
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: MAST program
Mixed Aerobic and Strength Training program (MAST): Each exercise session consisted of 10 minutes of warm-up, 15-30 minutes of interval aerobic training by cycle ergometer according to the program, 20 minutes of strength training exercises, and 10 minutes of cool-down by stretching.
|
MAST program: twice a week for 4 months
|
|
Inget ingripande: UC
Usual Care (UC) with Educational Lectures: No exercise sessions.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Maximal Oxygen Uptake
Tidsram: At baseline and after 4 months of intervention
|
To obtain peak oxygen uptake (VO2max; ml-1/min-1/kg), a symptom-limited exercise stress test was performed on a cycle ergometer.
The test was preceded by a 2-minute warm-up at the intensity of 20 W. The first test load was 20 W, and was increased by 20 W at each 2-minute stage until the participants could no longer continue, i.e., they were unable to maintain pedaling frequency > 40 rpm, they achieved a respiratory exchange ratio of more than 1.0, or clinical criteria for test termination was observed.
VO2max was measured and monitored with a breath-by-breath gas exchange system.
|
At baseline and after 4 months of intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Cerebral Blood Flow Velocity (BFV)
Tidsram: At baseline and after 4 months of intervention
|
Cerebral BFV was monitored using Transcranial Doppler Ultrasound.11
The middle cerebral artery was insonated from the temporal window by placing the 2-MegaHertZ (MHz) probe against the skin of the temporal region above the zygomatic arch.
The probe was positioned to obtain maximal BFV and was fixed at the desired angle using a 3-dimensional positioning system.
Once instrumented, BFV was continuously recorded throughout ten minutes of supine rest and 10-minutes on a table tilted to 80° from the horizontal position (head-up with foot plate support).
|
At baseline and after 4 months of intervention
|
|
Trail Making Test
Tidsram: At baseline and after 4 months of intervention
|
The Trail Making (TM) test is a measure of shifting attention.
Participants are required to sequentially connect a series of numbered circles (Part A), and then to alternate between numbers and letters sequentially (Part B) (e.g., A-1-B-2-C-3..).
Any participant who has not completed Part B within the standard 5 minutes (300 seconds) allotted for the task will be considered unable to complete the task.
The scores in Part A (TM-A), Part B (TM-B) T scores ( age, education adjusted), and their difference (TM-B -TM-A) were calculated and used to measure executive function, i.e., lower scores indicates better performance.
|
At baseline and after 4 months of intervention
|
|
Muscle Strength
Tidsram: At baseline and after 4 months of intervention
|
MAST sessions were held twice a week for 16 weeks.
Each exercise session consisted of 10 min of warm-up, 15-30 min of interval aerobic training by cycle ergometer according to the program, 20 min of strength training exercises, and 10 min of cool-down by stretching.
The target heart rate (HR) increased progressively from 50% up to 80% of HR reserve by the end of the intervention period.The Karvonen formula ([(HRmax - HRrest)×(0.50 to 0.80)] + HRrest) was used to calculate the target HR.
During every training session a new wireless computerized ECG monitoring system was used.
After aerobic training, the strength training program was performed.
Exercises used body mass as resistance and included squat, step-up-squat, step-up, heel rise, and sit-ups.
Dumbbells were used as extra weight (5 or 10% of body weight) during other exercises except for sit-ups.
The control group participated in an educational session once a month and kept physical activity diaries during the intervention period.
|
At baseline and after 4 months of intervention
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Vera Novak, MD, PhD, Beth Israel Deaconess Medical Center
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 juli 2009
Primärt slutförande (Faktisk)
1 maj 2010
Avslutad studie (Faktisk)
1 december 2013
Studieregistreringsdatum
Först inskickad
26 juni 2009
Först inskickad som uppfyllde QC-kriterierna
26 juni 2009
Första postat (Uppskatta)
29 juni 2009
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
13 november 2017
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
2 november 2017
Senast verifierad
1 november 2017
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2009P000121
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .